A COVID-19 Outlook: Progress on antiviral drugs and vaccine development
Bringing a new drug to market is a complex process with innumerable possible twists and turns. With a huge global research effort focused on SARS-CoV-2, the novel coronavirus causing COVID-19, what does that mean for the development of antiviral drugs and vaccines? What kind of jobs are in COVID-related research?
If you’re interested in learning more about the journey of drug discovery and the diverse job opportunities for newcomers to the field, please join Edward Rozhon, Ph.D., in a discussion about what’s involved in obtaining FDA approval to market antiviral drugs and vaccines—the scientific challenges, controversies, and socio-political and ethical issues.
Seeking a job in virology?
Dr. Rozhon, chair of the UCSC Extension Biotechnology and Clinical Trials Design and Management certificate programs, has advice for newcomers to the field and professionals looking for a job in the age of SARS-CoV-2.
You are invited to send in questions when you register and there will be time for Q&A during the presentation.
With an academic background in virology, Dr. Rozhon has devoted his career of nearly four decades to the study of viral diseases in academia and in the biopharmaceutical industry. His areas or research include the genetics underlying the viral mechanisms of disease and drug discovery efforts to treat HIV/AIDS, herpes viruses, and several respiratory viruses.
Dr. Rozhon teaches Principles of Drug Discovery and Development, Viruses, Vaccines and Antiviral Therapy, and Clinical Trials Essentials: An Intensive One-Week Course.
ABOUT JOB MARKET INSIGHTS
Job Market Insights is a weekly community discussion providing strategies for professional success in this crazy job market. It is hosted by UCSC Silicon Valley Extension, the professional development arm of UC Santa Cruz.
Image of of Novel Coronavirus SARS-CoV-2 is from NIAID-Rocky Mountain Laboratories
Wednesday, July 29 at 5:30pm to 6:30pm